Bluefin Capital Management’s Elevance Health ELV Stock Holding History

Bluefin Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-21,600	Closed	-$302K	–	537
2016 Q1	$302K	Sell	21,600 -10,000	-32%	-$1.34M	0.03%	239
2015 Q4	$422K	Buy	+31,600	New	+$4.35M	0.03%	324
2014 Q4	–	Sell	-244,900	Closed	-$152K	–	735
2014 Q3	$152K	Buy	244,900 +243,359	+15,792%	+$27.9M	0.01%	615
2014 Q2	$200K	Buy	+1,541	New	+$159K	0.01%	596

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Bluefin Capital Management's ELV Position: Q1 2022 in Review

Bluefin Capital Management sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 6,900 shares — an estimated $3.2M sold.

Bluefin Capital Management first reported a position in ELV in Q2 2014 and held it in 7 quarters. The position peaked at $15.3M in Q3 2014. 1,418 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

Bluefin Capital Management reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
Bluefin Capital Management sold 6,900 Elevance Health shares in Q1 2022, an estimated $3.2M.
Bluefin Capital Management first reported a position in Elevance Health in Q2 2014 and held it in 7 quarters.
Bluefin Capital Management's Elevance Health position peaked at $15.3M in Q3 2014.
1,418 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.